333 related articles for article (PubMed ID: 21392266)
21. Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1.
Ranganath LR
J Clin Pathol; 2008 Apr; 61(4):401-9. PubMed ID: 18375745
[TBL] [Abstract][Full Text] [Related]
22. The incretins: a link between nutrients and well-being.
Burcelin R
Br J Nutr; 2005 Apr; 93 Suppl 1():S147-56. PubMed ID: 15877888
[TBL] [Abstract][Full Text] [Related]
23. Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide.
Kuhre RE; Wewer Albrechtsen NJ; Hartmann B; Deacon CF; Holst JJ
J Diabetes Complications; 2015 Apr; 29(3):445-50. PubMed ID: 25623632
[TBL] [Abstract][Full Text] [Related]
24. Expression of Gastrin Family Peptides in Pancreatic Islets and Their Role in β-Cell Function and Survival.
Khan D; Vasu S; Moffett RC; Irwin N; Flatt PR
Pancreas; 2018 Feb; 47(2):190-199. PubMed ID: 29329158
[TBL] [Abstract][Full Text] [Related]
25. An analysis of cosecretion and coexpression of gut hormones from male rat proximal and distal small intestine.
Svendsen B; Pedersen J; Albrechtsen NJ; Hartmann B; Toräng S; Rehfeld JF; Poulsen SS; Holst JJ
Endocrinology; 2015 Mar; 156(3):847-57. PubMed ID: 25535831
[TBL] [Abstract][Full Text] [Related]
26. [Incretin and bone].
Yamada Y
Clin Calcium; 2009 Sep; 19(9):1312-7. PubMed ID: 19721203
[TBL] [Abstract][Full Text] [Related]
27. Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From Apoptosis.
Linnemann AK; Neuman JC; Battiola TJ; Wisinski JA; Kimple ME; Davis DB
Mol Endocrinol; 2015 Jul; 29(7):978-87. PubMed ID: 25984632
[TBL] [Abstract][Full Text] [Related]
28. Gastric inhibitory polypeptide and glucagon-like peptide-1(7-36) amide exert similar effects on somatostatin secretion but opposite effects on gastrin secretion from the rat stomach.
Jia X; Brown JC; Kwok YN; Pederson RA; McIntosh CH
Can J Physiol Pharmacol; 1994 Oct; 72(10):1215-9. PubMed ID: 7882187
[TBL] [Abstract][Full Text] [Related]
29. Pharmacology, physiology, and mechanisms of incretin hormone action.
Campbell JE; Drucker DJ
Cell Metab; 2013 Jun; 17(6):819-837. PubMed ID: 23684623
[TBL] [Abstract][Full Text] [Related]
30. Incretin actions beyond the pancreas: lessons from knockout mice.
Yabe D; Seino Y
Curr Opin Pharmacol; 2013 Dec; 13(6):946-53. PubMed ID: 24095602
[TBL] [Abstract][Full Text] [Related]
31. Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses.
Rohde U; Sonne DP; Christensen M; Hansen M; Brønden A; Toräng S; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
J Clin Endocrinol Metab; 2016 May; 101(5):2076-83. PubMed ID: 27003305
[TBL] [Abstract][Full Text] [Related]
32. The biology of cholecystokinin and gastrin peptides.
Rehfeld JF; Friis-Hansen L; Goetze JP; Hansen TV
Curr Top Med Chem; 2007; 7(12):1154-65. PubMed ID: 17584137
[TBL] [Abstract][Full Text] [Related]
33. Reduced ghrelin, islet amyloid polypeptide, and peptide YY expression in the stomach of gastrin-cholecystokinin knockout mice.
Friis-Hansen L; Wierup N; Rehfeld JF; Sundler F
Endocrinology; 2005 Oct; 146(10):4464-71. PubMed ID: 16002530
[TBL] [Abstract][Full Text] [Related]
34. Cholecystokinin, glucose dependent insulinotropic peptide and glucagon-like peptide 1 secretion in children with anorexia nervosa and simple obesity.
Tomasik PJ; Sztefko K; Starzyk J
J Pediatr Endocrinol Metab; 2004 Dec; 17(12):1623-31. PubMed ID: 15645696
[TBL] [Abstract][Full Text] [Related]
35. Gastrin secretion in normal subjects and diabetes patients is inhibited by glucagon-like peptide 1: a role in the gastric side effects of GLP-1-derived drugs?
Rehfeld JF; Knop FK; Asmar M
Scand J Gastroenterol; 2019 Dec; 54(12):1448-1451. PubMed ID: 31725337
[No Abstract] [Full Text] [Related]
36. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances.
Asmar M; Holst JJ
Curr Opin Endocrinol Diabetes Obes; 2010 Feb; 17(1):57-62. PubMed ID: 19881341
[TBL] [Abstract][Full Text] [Related]
37. Cholecystokinin in the regulation of gastric acid and endocrine pancreatic secretion in humans.
Konturek JW; Stoll R; Gutwinska-Konturek M; Konturek SJ; Domschke W
Scand J Gastroenterol; 1993 May; 28(5):401-7. PubMed ID: 8511500
[TBL] [Abstract][Full Text] [Related]
38. Leucine (and lysine) increased plasma levels of the satiety hormone cholecystokinin (CCK), and phenylalanine of the incretin glucagon-like peptide 1 (GLP-1) after oral gavages in pigs.
Müller M; Xu C; Navarro M; Masiques NE; Tilbrook A; van Barneveld R; Roura E
J Anim Sci; 2023 Jan; 101():. PubMed ID: 37233611
[TBL] [Abstract][Full Text] [Related]
39. Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas.
Saillan-Barreau C; Dufresne M; Clerc P; Sanchez D; Corominola H; Moriscot C; Guy-Crotte O; Escrieut C; Vaysse N; Gomis R; Tarasova N; Fourmy D
Diabetes; 1999 Oct; 48(10):2015-21. PubMed ID: 10512367
[TBL] [Abstract][Full Text] [Related]
40. Apelin stimulates both cholecystokinin and glucagon-like peptide 1 secretions in vitro and in vivo in rodents.
Wattez JS; Ravallec R; Cudennec B; Knauf C; Dhulster P; Valet P; Breton C; Vieau D; Lesage J
Peptides; 2013 Oct; 48():134-6. PubMed ID: 23954476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
